（文章来源：证券日报） 证券日报网讯 7月31日晚间，三元生物发布公告称，公司2025年第三次临时股东大会于2025年7月31日 召开，审议通过了《关于增加公司经营场所及修订的议案》。 ...

天眼查商业履历信息显示，山东三元生物科技股份有限公司，成立于2007年，位于滨州市，是一家以从 事食品制造业为主的企业。企业注册资本20232.57万人民币，实缴资本11166.34万人民币。公司法定代 表人为聂在建。 通过天眼查大数据分析，山东三元生物科技股份有限公司共对外投资了3家企业，参与招投标项目7次， 知识产权方面有商标信息8条，专利信息44条，此外企业还拥有行政许可21个。 金融界消息 截至2025年7月31日收盘，三元生物（301206）报收于29.09元，下跌2.22%，换手率2.4%， 成交量2.58万手，成交金额7561.84万元。 资金流向方面，今日主力资金净流出1026.11万元，占比成交额13.57%。其中，超大单净流出162.53万 元、占成交额2.15%，大单净流出863.58万元、占成交额11.42%，中单净流出流出95.90万元、占成交额 1.27%，小单净流入1122.02万元、占成交额14.84%。 三元生物最新一期业绩显示，截至2025一季报，公司营业总收入1.50亿元、同比减少21.73%，归属净利 润2491.40万元，同比增长2.75%，扣非净利润2090.42万 ...

北京市东城区建国门内大街 26 号新闻大厦 7 层、8 层 电话：010-88004488/66090088 传真：010-66090016 邮编：100005 北京国枫律师事务所 关于山东三元生物科技股份有限公司 2025 年第三次临时股东大会的 2．本所律师无法对网络投票过程进行见证，参与本次会议网络投票的股东资格、 网络投票结果均由深圳证券交易所交易系统和互联网投票系统予以认证； 1 3．本所及经办律师依据《证券法》《证券法律业务管理办法》《证券法律业务执业 规则》等规定及本法律意见书出具日以前已经发生或者存在的事实，严格履行了法定职 责，遵循了勤勉尽责和诚实信用原则，进行了充分的核查验证，保证本法律意见所认定 的事实真实、准确、完整，所发表的结论性意见合法、准确，不存在虚假记载、误导性 陈述或者重大遗漏，并承担相应法律责任； 4．本法律意见书仅供贵公司本次会议之目的使用，不得用作任何其他用途。本所 律师同意将本法律意见书随贵公司本次会议决议一起予以公告。 法律意见书 国枫律股字[2025]A0375 号 致：山东三元生物科技股份有限公司（贵公司） 北京国枫律师事务所（以下简称"本所"）接受贵公司的委托 ...

证券代码：301206 证券简称：三元生物 公告编号：2025-067 山东三元生物科技股份有限公司 2025 年第三次临时股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1、本次股东大会未出现否决议案的情形。 2、本次股东大会未涉及变更以往股东大会已通过的决议。 一、会议召开和出席情况 （一）会议召开情况 1、会议召开时间： 现场会议时间：2025 年 7 月 31 日（星期四）15:00 网络投票时间：通过深圳证券交易所交易系统进行网络投票的具体时间为： 2025 年 7 月 31 日 9:15—9:25，9:30—11:30 和 13:00—15:00；通过深圳证券交易 所互联网投票系统的具体时间为：2025 年 7 月 31 日 9:15 至 15:00 2、会议召开地点：山东省滨州市滨北梧桐十路 101 号三元生物公司会议室 3、会议召开方式：现场表决和网络表决相结合的方式 4、会议召集人：董事会 5、会议主持人：董事长聂在建 6、召开情况合法、合规、合章程性说明：本次会议的召集、召开与表决程 序符合《公司法》《深圳证券 ...

三元生物主营业务为食品饮料及合成生物相关领域，公司位于山东省滨州市。 公司将于2025年7月31日下午15：00召开第三次临时股东大会，审议《关于增加公司经营场所及修订 < 公司章程> 的议案》。 截至2025年7月30日15时，三元生物股价报29.75元，较前一交易日下跌0.25元，跌幅0.83%。当日开盘 价为29.94元，最高触及30.10元，最低下探至29.51元，成交量为21652手，成交额0.65亿元。 7月30日主力资金净流出252.32万元，占流通市值比例为0.08%。 风险提示：市场有风险，投资需谨慎。 ...

Core Viewpoint - The announcement by Sanyuan Biotech regarding the preliminary ruling of the U.S. anti-dumping investigation on erythritol indicates a significant potential impact on the company's operations and market strategy due to a high anti-dumping tax rate of 450.64% [3][4]. Group 1: Investigation and Tax Implications - Sanyuan Biotech has been subjected to a preliminary anti-dumping tax of 450.64% as a mandatory respondent in the U.S. Department of Commerce's investigation [3]. - The investigation is ongoing, and the final ruling is expected to be announced on November 23, 2025 [3]. - Cargill, Incorporated has initiated a request for anti-dumping and countervailing investigations against erythritol products originating from China [3]. Group 2: Market Impact and Strategic Response - The ongoing anti-dumping and countervailing investigations have negatively affected Sanyuan Biotech's sales in the U.S. market [4]. - The company is shifting its sales strategy from an export-focused approach to a balanced domestic and international strategy, emphasizing the domestic health consumer market [4]. - Sanyuan Biotech is also expanding into emerging markets in Southeast Asia, India, the Middle East, and along the Belt and Road Initiative to mitigate the adverse effects of the U.S. market situation [4]. Group 3: Financial Performance and Market Position - Sanyuan Biotech, a leading domestic erythritol producer, entered the capital market in 2022, benefiting from a booming sugar substitute market [4]. - However, the company has faced significant challenges, including oversupply in the sugar substitute market leading to price declines and the negative impact of the anti-dumping investigation, resulting in a substantial drop in stock price [4]. - Despite some improvement in performance, the company's stock price remains low, indicating ongoing growth challenges [5].

Core Viewpoint - The news highlights the efforts of Binzhou District in promoting industrial development through innovation, digital transformation, and the establishment of a favorable business environment, aiming to enhance the competitiveness of its "champion products" and industries on both domestic and international stages [2][3][4]. Group 1: Industrial Development Strategy - Binzhou District focuses on a strategy of "industrial strength and wealth" to drive high-quality industrial development, emphasizing high-end, intelligent, and green growth [2]. - The district has developed 11 products, including solid caustic soda and erythritol, that rank first in global or national production capacity, showcasing the strength of "Binzhou manufacturing" [2]. Group 2: Innovation and Technology - The district has implemented policies to promote technological innovation and high-quality industrial development, encouraging companies to increase R&D investment and establish high-level research platforms [2]. - Currently, 61.67% of large-scale industrial enterprises in the district engage in R&D activities, indicating a strong focus on innovation [2]. Group 3: Industrial Upgrading and New Industries - The district aims to upgrade its industrial structure by investing 9.48 million yuan in industrial technological transformation, with an investment growth rate exceeding 30% [3]. - There is a focus on developing strategic emerging industries such as biomanufacturing and new materials, with 90 provincial-level specialized and innovative small and medium-sized enterprises cultivated [3]. Group 4: Business Environment and Support - The district emphasizes creating a comfortable business environment, achieving a 99.6% electronic registration rate for enterprises, and providing targeted support to meet financing needs of 677 million yuan [4]. - The district has implemented a quality and brand strategy, with the brand value of Zhongyu Food reaching 5.284 billion yuan, ranking fifth among national food processing enterprises [4]. Group 5: Future Development Plans - Binzhou District plans to further promote new industrialization, strengthen the integration of technological and industrial innovation, and build a modern industrial system led by technological innovation [4].

证券代码：301206 证券简称：三元生物 公告编号：2025-065 山东三元生物科技股份有限公司 2025 年第三次临时股东大会通知公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 山东三元生物科技股份有限公司（以下简称"公司"）第五届董事会第七次 会议决定于 2025 年 7 月 31 日（星期四）召开公司 2025 年第三次临时股东大会， 现将本次会议有关事项通知如下： （三）会议召开的合法、合规性：本次股东大会会议召开符合有关法律、行 政法规、部门规章、规范性文件和《公司章程》的规定。 （四）会议召开的日期、时间： 1、现场会议召开时间：2025 年 7 月 31 日（星期四）15:00 2、网络投票时间：2025 年 7 月 31 日（星期四） （1）通过深圳证券交易所交易系统进行网络投票的时间为 2025 年 7 月 31 日 9:15-9:25，9:30-11:30，13:00-15:00。 （2）通过深圳证券交易所互联网系统投票的时间为 2025 年 7 月 31 日 9:15-15:00 （五）会议的召开方式：本次股东大会采用现场表决与 ...

Group 1 - The company Chutianlong is actively exploring and promoting the implementation of digital currency bridge scenarios, but faces risks related to new technology research and development and commercial application not meeting expectations [6] - Sanwei Biological received the preliminary ruling result of the anti-dumping investigation on erythritol from the US Department of Commerce, with a 450.64% anti-dumping duty applicable to the company [6] Group 2 - Sitwei expects a year-on-year net profit increase of 140% to 180% for the first half of the year [7] - Pop Mart anticipates a profit growth of no less than 350% for the six months ending June 30, 2025, compared to the same period last year [7] - Zhongsheng High-Tech is planning a change in company control, with its stock suspended from trading starting July 16 [7] - Sinochem International intends to acquire 100% equity of Nantong Xingchen, with its stock also suspended from trading starting July 16 [7] - *ST Yazhen's stock is under suspension for verification due to abnormal trading fluctuations starting July 16 [7] - Yanshan Technology's wholly-owned subsidiary is participating in the establishment of a partnership, which will ultimately invest in Bytedance Ltd. in equity form [7] - Bertley plans to jointly establish a partnership with Jinding Private Equity, focusing on investments in unlisted companies in the field of humanoid robots [7] - *ST Weir intends to purchase 51% of Zijiang New Materials for 546 million yuan, entering the lithium battery materials industry [7] - Dahua Technology's controlling subsidiary Huairui Technology is adjusting to be listed on the Hong Kong Stock Exchange [7]

Key Points - Zhongsheng Gaoke is planning a change in company control, with a potential transfer of 22.35% of shares at a valuation of 2.5 billion yuan, leading to a stock suspension starting July 16, 2025 [3][4] - Yanshan Technology's subsidiary is participating in a partnership to invest 41.64 million yuan in a fund that will ultimately invest in Bytedance Ltd [5] - Sanyuan Bio received an initial ruling of a 450.64% anti-dumping duty from the US Department of Commerce on erythritol, prompting a shift in sales strategy towards domestic markets [6] - Chutianlong is exploring digital currency projects but faces risks related to new technology development and commercial application [7] - Bertley is establishing a partnership to invest in humanoid robots and other emerging sectors, committing 198 million yuan [8] - China Merchants Highway's chairman resigned due to reaching retirement age [9] - Tibet Summit's controlling shareholder is under investigation for information disclosure violations, but it will not affect the company's operations [10][11] - ST Weir plans to acquire 51% of Zijiang New Materials for 546 million yuan, entering the lithium battery materials sector [12] - ST Yazhen's stock will be suspended for three days due to abnormal trading fluctuations [13] - Dahua Technology's subsidiary is shifting its listing to the Hong Kong Stock Exchange [14] Performance Forecasts - Zhongji Xuchuang expects a net profit increase of 52.64% to 86.57% for the first half of 2025, driven by strong demand for high-end optical modules [15] - Juchip Technology anticipates a 122.28% increase in net profit for the same period, benefiting from successful AI audio chip promotions [16] - Sitwei forecasts a net profit growth of 140% to 180%, with significant revenue increases from smartphone collaborations [17] - Tianyu Co. expects a net profit increase of 144.29% to 238.25%, aided by improved product structure and market strategies [18] - Jinli Yongci predicts a net profit growth of 151% to 180%, focusing on renewable energy and related sectors [19] - Blue Ocean Huaten expects a net profit increase of 152.76% to 190.68%, driven by growth in the new energy heavy truck market [20] - Maiqu'er anticipates a turnaround with a net profit of 1.4 million to 2 million yuan, compared to a loss in the previous year [21] - China Galaxy expects a net profit increase of 45% to 55%, with growth across various business segments [23] - Baicheng Pharmaceutical forecasts a significant decline in net profit, down 95.53% to 100% [24] Major Contracts - Jincheng signed a contract worth approximately 52.98 million USD for underground mining operations in the Democratic Republic of Congo [25] - ST Yundong entered a strategic cooperation agreement for drone development and investment with two companies [26] - Changgao Electric New's subsidiary won contracts totaling 445 million yuan from the State Grid [27] Shareholding Changes - Angli Education plans to reduce its repurchased shares by up to 573.1 million shares [28][29] - Lingzhi Software's shareholders plan to collectively reduce their holdings by up to 2.11% [30] - Founder Technology's major shareholder intends to reduce its stake by up to 2.27% [31] - Zhongfu Shenying's shareholder plans to reduce its stake by up to 1% [32] - Hangzhou Bank's shareholder intends to reduce its stake by up to 0.7% [33] - Haoyun Technology's chairman plans to reduce his stake by up to 400,000 shares [34] Financing Activities - Yuanwang Valley plans to raise up to 300 million yuan through a private placement for RFID production line projects and working capital [35]